Anatara Lifesciences (ASX:ANR) has provided an update on the recruitment progress for Stage 2 of its pivotal GaRP-IBS - irritable bowel syndrome - trial.
-
Latest News
Alterity Therapeutics completes last patient visit in ATH434-201 trial in multiple system atrophy
December 5, 2024 -
AusBiotech
AusBiotech Celebrates Early-Stage Innovation Forum winners
December 5, 2024 -
Latest News
Race submits human ethics application package for RC220 Phase 1 solid tumour trial
December 5, 2024
-
Latest News Anatara provides irritable bowel syndrome clinical trial update December 5, 2024
-
Latest News Digital health company Adherium secures R&D loan facility December 5, 2024Australian digital inhaler technology company Adherium (ASX:ADR) has entered into a $674,000 R&D loan facility with Endpoints Capital.
-
Latest News Acrux says US FDA approves its nitroglycerin ointment for moderate to severe pain December 5, 2024Acrux CEO and managing director Michael Kotsanis said, “We are very pleased to receive FDA approval for another ANDA product which has been developed in house by the Acrux R&D team."
-
Latest News Albanese Government launches review of Australia’s research and development December 3, 2024AusBiotech CEO Rebekah Cassidy expressed support for the review, emphasising the need for a unified approach to enhance Australia's R&D ecosystem.
-
Latest News Brisbane health-tech unveils advanced manufacturing facility December 3, 2024Brisbane health-tech company WearOptimo has unveiled the initial $7 million phase of its advanced manufacturing facility to produce its microwearable sensor.
-
Latest News AusBiotech welcomes experienced industry executive to its board December 3, 2024Dr Dell Kingsford Smith joins the AusBiotech board with more than 20 years of experience in clinical and commercial strategy across medical technology, pharmaceuticals, and vaccines.
-
Latest News 4DMedical signs contract to expand in Western Australia December 3, 2024Respiratory imaging technology company 4DMedical Limited (ASX:4DX) has signed a commercial contract with Perth Radiological Clinics to deliver its XV Technology-enabled ventilation reports across an initial 16 clinics in Perth.
-
Latest News Orthocell says it has achieved all endpoints in pivotal of nerve repair product December 3, 2024Regenerative medicine company Orthocell (ASX:OCC) has announced the successful completion of its Remplir 510(k) nerve repair study.
-
Latest News Macquarie University spinout secures landmark funding for breakthrough ALS gene therapy November 28, 2024Celosia Therapeutics, an Australian biotechnology company developing advanced gene therapies for neurodegenerative diseases, has raised $16.75 million to advance its program for amyotrophic lateral sclerosis disease.
-
AusBiotech AusBiotech and MTPConnect release summit communique November 28, 2024AusBiotech and MTPConnect jointly delivered Australia’s first National Biotech and Medtech Development and Commercialisation Summit in Canberra last week.
-
Latest News Australian-backed triple-combination hypertension treatment proceeding to regulatory submission November 28, 2024Australian-supported research recently published in three leading medical journals has confirmed positive Phase 3 clinical trial results for a triple combination that could revolutionise the management and treatment of high blood pressure.
-
Latest News Island Pharmaceuticals says ISLA-101 shows anti-dengue activity in Phase 2a study readout November 28, 2024Australian antiviral drug development company Island Pharmaceuticals Ltd (ASX:ILA) has announced that ISLA-101 has shown safety and anti-dengue activity in the Phase 2a cohort of the PROTECT Phase 2a/b trial.
-
Latest News Vaxxas expands global IP portfolio for exclusive manufacture and sale of needle-free vaccination technology November 28, 2024Australian clinical-stage biotechnology company Vaxxas has expanded its global intellectual property portfolio to 42 patents, supporting its exclusive claim to manufacture and sell its proprietary vaccination technology, the HD-MAP, in the US, Europe, Asia and Australia.
-
Latest News GE HealthCare and Peter MacCallum Cancer Centre partner to advance cancer research November 26, 2024GE HealthCare and Peter MacCallum Cancer Centre have announced a partnership under which the Melbourne-based facility will evaluate a new positron emission tomography and computed tomography technology
-
AusBiotech AusBiotech congratulates Professor David Thomas on receiving cancer research award November 26, 2024“Professor David Thomas is a visionary leader in genomic cancer medicine, whose work has not only transformed outcomes for patients but has also positioned Australia as a global leader in precision oncology," said AusBiotech CEO Rebekah Cassidy.
-
Latest News Omico's Professor David Thomas receives NSW Premier’s Award for Outstanding Cancer Researcher November 26, 2024Professor David Thomas said, “We are on the cusp of a new era in cancer care. It’s imperative to integrate this approach as mainstream care for all Australians.”
-
Latest News LBT Innovations announces name change, to Clever Culture Systems November 26, 2024CEO and managing director Brent Barnes said, “With the growing sales momentum of APAS, we believe now is the ideal time to streamline and simplify communications with our customers and shareholders under the unified identity of Clever Culture Systems.”
New Stories
-
AusBiotech Celebrates Early-Stage Innovation Forum winners
December 5, 2024 - - AusBiotech -
Race submits human ethics application package for RC220 Phase 1 solid tumour trial
December 5, 2024 - - Latest News -
Alterity Therapeutics completes last patient visit in ATH434-201 trial in multiple system atrophy
December 5, 2024 - - Latest News -
Digital health company Adherium secures R&D loan facility
December 5, 2024 - - Latest News -
Acrux says US FDA approves its nitroglycerin ointment for moderate to severe pain
December 5, 2024 - - Latest News -
Anatara provides irritable bowel syndrome clinical trial update
December 5, 2024 - - Latest News -
Albanese Government launches review of Australia’s research and development
December 3, 2024 - - Latest News